Risk prediction models for incident primary cutaneous melanoma: a systematic review.

IMPORTANCE Currently, there is no comprehensive assessment of melanoma risk prediction models. OBJECTIVE To systematically review published studies reporting multivariable risk prediction models for incident primary cutaneous melanoma for adults. EVIDENCE REVIEW EMBASE, MEDLINE, PREMEDLINE, and Cochrane databases were searched to April 30, 2013. Eligible studies were hand searched and citation tracked. Two independent reviewers extracted information. FINDINGS Nineteen studies reporting 28 melanoma prediction models were included. The number of predictors in the final models ranged from 2 to 13; the most common were nevi, skin type, freckle density, age, hair color, and sunburn history. There was limited reporting and substantial variation among the studies in model development and performance. Discrimination (the ability of the model to differentiate between patients with and without melanoma) was reported in 9 studies and ranged from fair to very good (area under the receiver operating characteristic curve, 0.62-0.86). Few studies assessed internal or external validity of the models or their use in clinical and public health practice. Of the published melanoma risk prediction models, the risk prediction tool developed by Fears and colleagues, which was designed for the US population, appears to be the most clinically useful and may also assist in identifying high-risk groups for melanoma prevention strategies. CONCLUSIONS AND RELEVANCE Few melanoma risk prediction models have been comprehensively developed and assessed. More external validation and prospective evaluation will help translate melanoma risk prediction models into useful tools for clinical and public health practice.

[1]  D. English,et al.  Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia , 1988 .

[2]  R. MacKie,et al.  PERSONAL RISK-FACTOR CHART FOR CUTANEOUS MELANOMA , 1989, The Lancet.

[3]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[4]  S. Walter,et al.  Use of host factors to identify people at high risk for cutaneous malignant melanoma . , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[5]  H. Soyer,et al.  Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. , 1994, The Journal of investigative dermatology.

[6]  R. Pill,et al.  Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score , 1998, BMJ.

[7]  M. Perlman,et al.  American College of Preventive Medicine policy statement: screening for skin cancer. , 1998, American journal of preventive medicine.

[8]  P Barbini,et al.  Instrumental measurement of skin colour and skin type as risk factors for melanoma: a statistical classification procedure , 1998, Melanoma research.

[9]  M T Landi,et al.  Combined risk factors for melanoma in a Mediterranean population , 2001, British Journal of Cancer.

[10]  Michael Binder,et al.  Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk , 2003, Melanoma research.

[11]  Donald R. Miller,et al.  The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. , 2003, Journal of the American Academy of Dermatology.

[12]  A. Chompret,et al.  Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. , 2004, Journal of the National Cancer Institute.

[13]  S. Chimenti,et al.  Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case–control study , 2004, Melanoma research.

[14]  D. Whiteman,et al.  A Risk Prediction Tool for Melanoma? , 2005, Cancer Epidemiology Biomarkers & Prevention.

[15]  Andrew N Freedman,et al.  Cancer risk prediction models: a workshop on development, evaluation, and application. , 2005, Journal of the National Cancer Institute.

[16]  Graham A Colditz,et al.  Risk factors and individual probabilities of melanoma for whites. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Allan Halpern,et al.  Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[19]  A. Evans,et al.  Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions , 2006, Annals of Internal Medicine.

[20]  D. Rigel,et al.  Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. , 2007, Journal of the American Academy of Dermatology.

[21]  Alan Geller,et al.  Visual screening for malignant melanoma: a cost-effectiveness analysis. , 2007, Archives of dermatology.

[22]  E. Steyerberg Clinical Prediction Models , 2008, Statistics for Biology and Health.

[23]  M. Spitz,et al.  An Expanded Risk Prediction Model for Lung Cancer , 2008, Cancer Prevention Research.

[24]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[25]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.

[26]  Therese Miller,et al.  Screening for Skin Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[27]  P. Royston,et al.  Prognosis and prognostic research: application and impact of prognostic models in clinical practice , 2009, BMJ : British Medical Journal.

[28]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: Developing a prognostic model , 2009, BMJ : British Medical Journal.

[29]  Paolo Pasquini,et al.  Identifying individuals at high risk of melanoma: a simple tool , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[30]  Patrick Royston,et al.  Reporting methods in studies developing prognostic models in cancer: a review , 2010, BMC medicine.

[31]  M. Kattan,et al.  Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. , 2010, European urology.

[32]  Patrick Royston,et al.  Reporting performance of prognostic models in cancer: a review , 2010, BMC medicine.

[33]  M. Thun,et al.  Performance of Common Genetic Variants in Breast-cancer Risk Models , 2022 .

[34]  Emily White,et al.  Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors. , 2011, Journal of clinical & experimental dermatology research.

[35]  John L Hopper,et al.  Risk Prediction Models for Colorectal Cancer: A Review , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[36]  B. Dréno,et al.  Development of an individual score for melanoma risk , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[37]  Andrew J Vickers,et al.  Prediction models in cancer care , 2011, CA: a cancer journal for clinicians.

[38]  R. Wolfe,et al.  Predicting melanoma risk for the Australian population , 2011, The Australasian journal of dermatology.

[39]  G. Giles,et al.  Early-life sun exposure and risk of melanoma before age 40 years , 2011, Cancer Causes & Control.

[40]  Richard D. Riley,et al.  A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance , 2012, Breast Cancer Research and Treatment.

[41]  M. Woodward,et al.  Risk prediction models: II. External validation, model updating, and impact assessment , 2012, Heart.

[42]  B. Dréno,et al.  Validation of the Self-Assessment of Melanoma Risk Score for a melanoma-targeted screening , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[43]  J. Paoli,et al.  Euromelanoma: a dermatology‐led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future , 2012, The British journal of dermatology.

[44]  W. Stolz,et al.  Development of a targeted risk‐group model for skin cancer screening based on more than 100 000 total skin examinations , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[45]  D. Polsky,et al.  Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure. , 2012 .

[46]  J. Ioannidis,et al.  Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study , 2013, PloS one.

[47]  J. Lortet-Tieulent,et al.  International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.

[48]  G. Glendon,et al.  A focus group study on breast cancer risk presentation: one format does not fit all , 2012, European Journal of Human Genetics.